Vitreous vascular cell adhesion molecule-1 levels in vitreoretinal pathologies: a prospective analysis of 181 eyes.

OBJECTIVE: To quantify vitreous vascular cell adhesion molecule-1 (VCAM-1) across vitreoretinal pathologies and identify associated factors. DESIGN: Prospective, single-centre, cross-sectional observational study. PARTICIPANTS: A total of 181 eyes of 171 adults undergoing pars plana vitrectomy (PPV). METHODS: Undiluted midvitreous specimens were aspirated before infusion. Eyes were formed into 5 subgroups: advanced proliferative diabetic retinopathy (n = 80), rhegmatogenous retinal detachment (n = 65), vitreomacular interface (VMI) disease (n = 17), retained lens fragments (n = 14), and endophthalmitis (n = 5). VCAM-1 was measured by sandwich enzyme-linked immunosorbent assay. VMI disease was the reference category; no disease-free controls existed. Log-transformed VCAM-1 was analysed by univariable and multivariable regression with Benjamini-Hochberg false discovery rate adjustment. RESULTS: VCAM-1 differed across subgroups (P < 0.001), greatest in endophthalmitis (45 972.61 ± SE 22 130.67 pg/mL; n = 5) and lowest in VMI disease (3669.46 ± 642.42 pg/mL). Chronic kidney disease (P = 0.031) and longer duration of diabetes (unstandardised coefficient B = 411.15 ± 173.65 pg/mL per year; P = 0.020) were associated with greater VCAM-1, although neither group survived false discovery rate adjustment (q = 0.109 and 0.093). Pre-existing glaucoma was independently associated with elevated VCAM-1 (20 126.36 ± 4784.77 vs 9946.15 ± 1147.22 pg/mL; P = 0.003; q = 0.021). CONCLUSIONS: Vitreous VCAM-1 varied across vitreoretinal diagnoses, greatest in endophthalmitis, although on only 5 eyes. Longer duration of diabetes, chronic kidney disease, and pre-existing glaucoma were each associated with greater VCAM-1. These cross-sectional associations are hypothesis-generating and do not establish a mechanistic or causal role.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2026-11-18
DOI
https://doi.org/10.1016/j.jcjo.2026.10.005
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Vitreous vascular cell adhesion molecule-1 levels in vitreoretinal pathologies: a prospective analysis of 181 eyes.

Varun Chaudhary, Tamam El‐Elimat, Seren Al Beiruti, Rami A. Al-Dwairi et al.
PubMed
Retinal Diseases and Treatments
article

Vitreous vascular cell adhesion molecule-1 levels in vitreoretinal pathologies: a prospective analysis of 181 eyes.

Varun Chaudhary, Tamam El‐Elimat, Seren Al Beiruti, Rami A. Al-Dwairi, Sahar Khademioore, Abdelwahab Aleshawi, Maryam Ghadimi, Ahmed Al Sharie, Salma Al-Etr, Aysha Alsarahin, John Vinitha, Jinhui Ma, João Pedro Lima
article en

Abstract

OBJECTIVE: To quantify vitreous vascular cell adhesion molecule-1 (VCAM-1) across vitreoretinal pathologies and identify associated factors. DESIGN: Prospective, single-centre, cross-sectional observational study. PARTICIPANTS: A total of 181 eyes of 171 adults undergoing pars plana vitrectomy (PPV). METHODS: Undiluted midvitreous specimens were aspirated before infusion. Eyes were formed into 5 subgroups: advanced proliferative diabetic retinopathy (n = 80), rhegmatogenous retinal detachment (n = 65), vitreomacular interface (VMI) disease (n = 17), retained lens fragments (n = 14), and endophthalmitis (n = 5). VCAM-1 was measured by sandwich enzyme-linked immunosorbent assay. VMI disease was the reference category; no disease-free controls existed. Log-transformed VCAM-1 was analysed by univariable and multivariable regression with Benjamini-Hochberg false discovery rate adjustment. RESULTS: VCAM-1 differed across subgroups (P < 0.001), greatest in endophthalmitis (45 972.61 ± SE 22 130.67 pg/mL; n = 5) and lowest in VMI disease (3669.46 ± 642.42 pg/mL). Chronic kidney disease (P = 0.031) and longer duration of diabetes (unstandardised coefficient B = 411.15 ± 173.65 pg/mL per year; P = 0.020) were associated with greater VCAM-1, although neither group survived false discovery rate adjustment (q = 0.109 and 0.093). Pre-existing glaucoma was independently associated with elevated VCAM-1 (20 126.36 ± 4784.77 vs 9946.15 ± 1147.22 pg/mL; P = 0.003; q = 0.021). CONCLUSIONS: Vitreous VCAM-1 varied across vitreoretinal diagnoses, greatest in endophthalmitis, although on only 5 eyes. Longer duration of diabetes, chronic kidney disease, and pre-existing glaucoma were each associated with greater VCAM-1. These cross-sectional associations are hypothesis-generating and do not establish a mechanistic or causal role.

PubMed
Jordan University of Science and Technology (JO), University of Toronto (CA), McMaster University (CA)
Retinal Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon